From Diagnostic Tool to Scientific Sovereign: The End of Human-Led Discovery

Artificial intelligence has transcended its role as a diagnostic assistant, evolving into an autonomous engine for scientific discovery and business execution. This shift compresses drug development from six years to under 18 months and challenges the post-labor economic paradigm, forcing a global recalibration of security and regulatory frameworks.